Trevena(TRVN)
搜索文档
Trevena(TRVN) - 2022 Q1 - Quarterly Report
2022-05-11 19:16
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36193 Trevena, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdicti ...
Trevena(TRVN) - 2021 Q4 - Earnings Call Transcript
2022-04-01 05:44
Trevena, Inc. (OTC:TRVN) Q4 2021 Earnings Conference Call March 31, 2022 8:00 AM ET Company Participants Barry Shin - Senior Vice President and Chief Financial Officer Carrie Bourdow - President and Chief Executive Officer Patricia Drake - Senior Vice President and Chief Commercial Officer Mark Demitrack - Senior Vice President and Chief Medical Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Jason Butler - JMP Securities Douglas Tsao - H.C. Wainwright & Co. Jeff Jones - Oppenheimer ...
Trevena(TRVN) - 2021 Q4 - Annual Report
2022-03-31 19:17
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36193 Trevena, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 26-1469215 (State or Other Juri ...
Trevena(TRVN) - 2021 Q3 - Earnings Call Transcript
2021-11-16 01:33
Trevena, Inc. (OTC:TRVN) Q3 2021 Earnings Conference Call November 15, 2021 8:00 AM ET Company Participants Barry Shin - Senior Vice President and Chief Financial Officer Carrie Bourdow - President and Chief Executive Officer Patty Drake - Chief Commercial Officer Bob Yoder - Chief Business Officer and Head, Commercial Operations Mark Demitrack - Chief Medical Officer Paul Ryder - Professor, University of South Alabama Conference Call Participants Jason Butler - JMP Securities Jeff Jones - Oppenheimer Chris ...
Trevena(TRVN) - 2021 Q3 - Quarterly Report
2021-11-15 20:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36193 Trevena, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisd ...
Trevena(TRVN) - 2021 Q2 - Earnings Call Presentation
2021-08-13 21:03
INNOVATING FOR PATIENTS Nasdaq TRVN I August 2021 Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts regarding Trevena, Inc. (the "Company" or "we"), they are forward-looking statements reflecting management's current beliefs and expectations. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry's actual results, levels of activity, performance, or a ...
Trevena(TRVN) - 2021 Q2 - Earnings Call Transcript
2021-08-13 01:04
Trevena, Inc (OTC:TRVN) Q2 2021 Earnings Conference Call August 12, 2021 8:00 AM ET Company Participants Barry Shin – Chief Financial Officer Carrie Bourdow – President and Chief Executive Officer Bob Yoder – Chief Commercial Officer Mark Demitrack – Chief Medical Officer Conference Call Participants Brandon Folkes – Cantor Fitzgerald Jason Butler – JBS Securities Douglas Tsao – H.C. Wainwright Operator Thank you for standing by, and welcome to the Trevena Incorporated Second Quarter 2021 Financial Results ...
Trevena(TRVN) - 2021 Q2 - Quarterly Report
2021-08-12 20:58
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware (State or Other Jurisdiction of Incorporation or Organization) 26-1469215 (I.R.S. Employer Identification No.) 955 Chesterbrook Boulevard, Suite 110 Chesterbrook, PA (Address of Principal Executive Offices) 19087 (Zip Code) For the quarterly period ended June 30, 2021 Or ☐ TRANSITION REPORT PURSUANT T ...
Trevena(TRVN) - 2021 Q1 - Earnings Call Transcript
2021-05-09 12:30
Trevena, Inc. (OTC:TRVN) Q1 2021 Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Barry Shin - SVP & CFO Carrie Bourdow - President, CEO & Director Robert Yoder - SVP & Chief Commercial Officer Mark Demitrack - SVP & Chief Medical Officer Conference Call Participants Jason Butler - JMP Securities Brandon Folkes - Cantor Fitzgerald & Co. Dana Flanders - Guggenheim Securities Jeffrey Jones - Oppenheimer Douglas Tsao - H.C. Wainwright & Co. Operator Good day, and thank you for standing by, ...
Trevena Investor Presentation - Slideshow
2021-05-08 14:28
INNOVATING FOR PATIENTS Nasdaq TRVN I May 2021 Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts regarding Trevena, Inc. (the "Company" or "we"), they are forward-looking statements reflecting management's current beliefs and expectations. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry's actual results, levels of activity, performance, or achi ...